| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
,
DAWN B MARKS,
TERRY M KANEFSKY,
VICTOR E ADLIN and
BERTRAM J CHANNICK
Department of Medicine, Section of Endocrinology, Temple University Health Sciences Center Philadelphia, Pennsylvania 19140
The plasma aldosterone response to infused angiotensin II was determined in normal controls and in patients with normal renin and with low renin essential hypertension. The patients with low renin essential hypertension showed an enhanced plasma aldosterone response when compared to the other two groups. This finding may explain why plasma aldosterone levels remain within normal limits in the face of suppressed plasma renin and angiotensin II concentrations in low renin essential hypertension. (JClin Endocrinol Metab 48: 266, 1979)
* This work was supported in part by an American Heart Association grant (Southeastern Pennsylvania Chapter) and Temple University Hospital General Clinical Research Center Grant 5M01RR349-11.
To whom requests for reprints should be addressed.
Received March 6, 1978.
This article has been cited by other articles:
![]() |
N. D. L. Fisher, S. Hurwitz, C. Ferri, X. Jeunemaitre, N. K. Hollenberg, and G. H. Williams Altered Adrenal Sensitivity to Angiotensin II in Low-Renin Essential Hypertension Hypertension, September 1, 1999; 34(3): 388 - 394. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. V. Adlin, A. D. Marks, and B. J. Channick Racial Difference in Salivary Sodium-Potassium Ratio in Low Renin Essential Hypertension Arch Intern Med, April 1, 1982; 142(4): 703 - 706. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |